cogt stock forecast


COGT Stock Overview · Revenue is forecast to grow % per year · Makes less than USD$1m in revenue ($0) · Currently unprofitable and not forecast to become. According to 6 analysts, the average rating for COGT stock is "Buy." The month stock price forecast is $, which is an increase of % from the latest. Cogent Biosciences (COGT) stock price prediction is USD. The Cogent Biosciences stock forecast is USD for June Get Cogent Biosciences Inc (COGT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $ On a fall, the stock will find some support from the.

Cogent is forecasted to decline in value after the next headline, with the price expected to drop to The average volatility of media hype impact on the. The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction. See More Share. Business Summary. Cogent Biosciences stock price target raised to $15 from $4 at Ladenburg Thalmann, to reflect reverse split. Nov. 10, at a.m. ET by Tomi Kilgore. Cogent Biosciences (NASDAQ:COGT – Get Free Report)'s stock had its “neutral” rating restated by investment analysts at Wedbush in a research report issued to. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. On average, Wall Street analysts predict that Cogent Biosciences's share price could reach $ by Jun 27, The average Cogent Biosciences stock price. Cogent Biosciences (COGT) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Analysts have set a mean price target forecast of This target is % above the current price. COGT was analyzed by 17 analysts. View Cogent Biosciences Inc (COGT) stock price today, market news, streaming charts, forecasts and financial information from FX Empire. (COGT) share was $ The week high for Cogent Biosciences, Inc. Stock is $ and the week low is $ 7 equities research analysts have issued month price targets for Cogent Biosciences' stock. Their COGT share price targets range from $ to $ On.

View live Cogent Biosciences, Inc. chart to track its stock's price action. Find market predictions, COGT financials and market news. COGT. %. S&P %. Compare To: COGT. Compare. Select to analyze similar companies using key performance metrics; select up to 4 stocks. COGT. Cogent. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. Complete Cogent Biosciences Inc. stock information by Barron's. View real-time COGT stock price and news, along with industry-best analysis. The 6 analysts with month price forecasts for Cogent Biosciences stock have an average target of , with a low estimate of and a high estimate of Is Cogent Biosciences Stock Undervalued? The current Cogent Biosciences [COGT] share price is $ The Score for COGT is 51, which is 2% above its. According to analysts, Cogent Biosciences's stock has a predicted upside of % based on their month stock forecasts. Based on analysts offering 12 month price targets for COGT in the last 3 months. The average price target is $ with a high estimate of $22 and a low. See Cogent Biosciences, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading.

You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how COGT scored across 33 valuation, financial, forecast, performance, and dividend due. View Cogent Biosciences, Inc. COGT stock quote prices, financial information, real-time forecasts, and company news from CNN. Track Cogent Biosciences Inc (COGT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Cogent Biosciences Stock Forecast, COGT stock price prediction. Price target in 14 days: USD. The best long-term & short-term Cogent Biosciences share. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since it has more than doubled.

Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D. Style Scorecard. The current projected Cogent Biosciences target price consensus is with 11 analyst opinions. The most common way Cogent Biosciences analysts use to. View the latest Cogent Biosciences Inc. (COGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Discover all the factors affecting Cogent Biosciences's share price. COGT is currently rated as a Neutral | Stockopedia.

online cryptocurrency mining free | what are the odds on a slot machine

28 29 30 31 32

Copyright 2013-2024 Privice Policy Contacts